e-learning
resources
Vienna 2012
Monday, 03.09.2012
Recent progress in mechanisms and diagnostics of COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases
J. Huang, A. Atrih, A. Barton, C. Palmer, G. Devereus (Dundee, Aberdeen, United Kingdom)
Source:
Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Session:
Recent progress in mechanisms and diagnostics of COPD and asthma
Session type:
Poster Discussion
Number:
1763
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Huang, A. Atrih, A. Barton, C. Palmer, G. Devereus (Dundee, Aberdeen, United Kingdom). Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases. Eur Respir J 2012; 40: Suppl. 56, 1763
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001
Role of BALF in differential diagnosis of smoking related interstitial lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006
Cytokine profiles in the lungs of patients with interstitial and obstructive lung diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Phenotypic analysis of BAL lympocytes and respiratory function in chronic inflammatory lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 543s
Year: 2005
BAL protein profiles specific of different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020
The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2016
Year: 2016
Interstitial lung diseases and systemic disorders with lung involvement
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017
Sputum cytokine profiling according to the type of airway inflammation in obstructive pulmonary diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Peroxidation processes, cytokines, BALF and blood cytology in patients with occupational lung diseases and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 275s
Year: 2002
The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006
Surfactant therapy for acute lung injury and other lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 210s
Year: 2003
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
Exhaled volatile organic compounds as biomarkers for respiratory diseases
Source: Eur Respir Monogr 2010; 49: 130-139
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept